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Background: The C5-hydroxylation reaction of 
coenzyme Q biosynthesis in Escherichia coli is 
catalyzed by an unknown enzyme. 
Results: The UbiI protein is responsible for the 
C5-hydroxylation reaction.  
Conclusion: The three monooxygenases involved 
in aerobic Q biosynthesis are now identified.  
Significance: We report the characterization of a 
gene of unknown function and the first crystal 
structure of a monooxygenase involved in Q 
biosynthesis. 
 
SUMMARY 
Coenzyme Q (ubiquinone or Q) is a 
redox active lipid found in organisms ranging 
from bacteria to mammals in which it plays a 
crucial role in energy generating processes. Q 
biosynthesis is a complex pathway which 
involves multiple proteins. In this work, we 
show that the uncharacterized conserved visC 
gene is involved in Q biosynthesis in 
Escherichia coli and we have renamed it ubiI. 
Based on genetic and biochemical experiments, 
we establish that the UbiI protein functions in 
the C5-hydroxylation reaction. A strain 
deficient for ubiI has low level of Q and 
accumulates a compound derived from the Q 
biosynthetic pathway, which we purified and 
characterized. We also demonstrate that UbiI is 
only implicated in aerobic Q biosynthesis and 
that an alternative enzyme catalyzes the C5-
hydroxylation reaction in the absence of 
oxygen. We have solved the crystal structure of 
a truncated form of UbiI. This structure shares 
many features with the canonical FAD-
dependent para-hydroxybenzoate hydroxylase 
(PHBH) and represents the first structural 
characterization of a monooxygenase involved 
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in Q biosynthesis.  Site directed mutagenesis 
confirms that residues of the flavin binding 
pocket of UbiI are important for activity. With 
our identification of UbiI, the three 
monooxygenases necessary for aerobic Q 
biosynthesis in E. coli are known.  
 
INTRODUCTION 
Coenzyme Q (ubiquinone or Q)7 is a 
widespread redox-active lipid essential for 
electron and proton transport in the respiratory 
chains from bacteria to mammals (1,2). Q is 
composed of a fully-substituted benzoquinone ring 
to which is attached a polyisoprenyl tail with a 
number of isoprenyl units varying from one 
species to another (6 in Saccharomyces cerevisiae, 
10 in humans and 8 in E. coli). Biosynthesis of Q 
is a highly conserved pathway, which involves a 
large number of genes that have been identified 
mostly from seminal genetic studies using S. 
cerevisiae and E. coli (3,4). However, our genetic 
understanding of Q biosynthesis is still incomplete 
and very few Q biosynthetic proteins have been 
isolated and characterized biochemically.  
Biosynthesis of Q8 in E. coli requires 9 
Ubi proteins (UbiA-H and UbiX), most of them 
are involved in reactions that modify the aromatic 
ring of the 4-hydroxybenzoic acid (4-HB) 
universal precursor (Fig. 1). After prenylation of 
4-HB catalyzed by UbiA, UbiX and UbiD are 
proposed to be involved in the decarboxylation 
(5).  Three methylation (reactions d, f, h, Fig. 1) 
and three hydroxylation reactions (on C5, C1 and 
C6, reactions c, e and g respectively) follow to 
yield Q8. UbiG catalyzes both O5- and O6-
methylation (6) while UbiE is the C2-
methyltransferase (7). The genes encoding the 
enzymes responsible for the aerobic C1- and C6-
hydroxylation reactions have been identified as 
ubiH and ubiF respectively (8,9) (Fig. 1). UbiF 
and UbiH share 32 % of sequence identity and are 
defined as members of class A flavoprotein 
monooxygenases from sequence analysis (10), 
even though they have not been isolated in pure 
form and characterized in vitro. In contrast, the 
gene responsible for the C5-hydroxylation reaction 
in E. coli (c on Fig. 1) remains unknown. UbiB 
has been proposed to be involved in this reaction 
based on the accumulation of 3-octaprenylphenol 
(OPP, Fig. 1) in a ubiB- strain (11,12). However, 
accumulation of OPP does not necessarily reflect a 
defect in C5-hydroxylation  since a strain deficient 
in the methyltransferase UbiG also accumulates 
OPP (13). Moreover, the primary sequence of 
UbiB does not contain any motif characteristic for 
hydroxylases but instead displays conserved 
motifs found in a superfamily of ancestral kinases 
(14). 
Searching the gene responsible for the C5-
hydroxylation, we reasoned that visC, a gene of 
unknown function, could be a good candidate to 
investigate because it locates immediately 
downstream of ubiH within the same operon (9). 
Furthermore, visC is predicted to encode a protein 
with the typical domains shared by flavoprotein 
monooxygenases and with 30 % and 39 % 
sequence identity to UbiH and UbiF respectively 
(Fig. S1)(10). In the present study, we report 
genetic and biochemical experiments which 
unambiguously establish that VisC participates to 
coenzyme Q8 biosynthesis by catalyzing the 
aerobic C5-hydroxylation reaction. We therefore 
propose to change the name of VisC into UbiI. We 
succeeded in purifying the protein and 
crystallizing a truncated form of UbiI. The crystal 
structure shows a high degree of similarity with 
that of parahydroxybenzoate hydroxylase (PHBH) 
a well characterized FAD-dependent 
monooxygenase (15).  Albeit incomplete, our 
structure of UbiI is the first crystal structure of a 
monooxygenase associated with ubiquinone 
biosynthesis.  
 
EXPERIMENTAL PROCEDURES 
 
Strains and Growth Conditions 
 
E. coli strains were grown in Luria-Bertani (LB)-
rich medium at 37 °C. Anaerobic cultures were 
performed in sealed 15mL falcon tubes filled to 
the top with culture medium. Strains used in this 
study are listed in Table S1. Ampicillin (50 µg/ml) 
and kanamycin (25 µg/ml) were added when 
necessary. All the strains are E. coli K-12 
derivatives. Strains JW2874, JW2875, JW0659 
and JW5581 from the Keio collection (16) were 
kindly provided by P. Moreau (LCB, Marseille)  
and were the donor of the ∆ubiI::kan, ∆ubiH::kan, 
∆ubiF::kan and ∆ubiE::kan mutations. The ∆ubiI 
strain was cured to yield ∆ubiIc which was then 
used to construct the ∆ubiF∆ubiI and ∆ubiE∆ubiI 
strains. Each mutation was transduced via P1 
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phage into MG1655. Mutations were confirmed 
using colony PCR with primers flanking the 
mutation.  
S. cerevisiae was transformed using lithium 
acetate and was grown in YNB without pABA and 
folate (MP Biomedicals) with the indicated carbon 
sources (17).  
 
Plasmid Construction 
 
Plasmids are listed in Table S1 and their 
construction is detailed in supplementary text.  
 
Quinones extraction and quantification by HPLC-
ECD analysis 
 
5 mL of cells in exponential phase were 
centrifuged and the pellet mass was determined. 
Glass beads (100 µL), 50 µL KCl 0.15M and a 
volume of a Q solution (used as an internal 
standard) proportional to the wet weight were 
added to cell pellet. Q10 was used for E. coli 
samples and Q4 for S. cerevisiae samples. Lipids 
extraction was performed by adding 0.6 mL of 
methanol, vortexing for 10 minutes then adding 
0.4 mL of petroleum ether (boiling range 40°C-
60°C) and vortexing for 3 min. The phases were 
separated by centrifugation 1 min, 5000 rpm. The 
upper petroleum ether layer was transferred to a 
fresh tube. Petroleum ether (0.4 mL) was added to 
the glass beads and methanol–containing tube, and 
the extraction was repeated. The petroleum ether 
layers were combined and dried under nitrogen. 
The dried samples were stored at -20°C and were 
resuspended in 100 µL of 98% ethanol, 20 mM 
lithium perchlorate. Aliquots were analyzed by 
reversed-phase high-perfomance liquid 
chromatography (HPLC) with a C18 column 
(Betabasic-18, 5 mm, 4.6 × 150 mm, Thermo 
Scientific) at a flow rate of 1 mL/min using 40% 
ethanol, 40% acetonitrile and 20% of a mix of 
90% isopropanol and 10% lithium perchlorate 
(1M) as a mobile phase. The mobile phase used to 
analyze yeast extracts was 5% isopropanol, 20% 
acetonitrile and 75% of a mix of 98% methanol 
and 2% lithium perchlorate (1M). Quinones were 
quantified with an ESA Coulochem III 
electrochemical detector (ECD) and a 5011A 
analytical cell (E1, -650 mV; E2, 650 mV). 
Hydroquinones present in samples were oxidized 
with a precolumn 5020 guard cell set in oxidizing 
mode (E, +650 mV). Different volumes of the 
standard Q
 
solutions were injected in the same 
conditions in order to correct for sample loss 
during the organic extraction on the basis of the 
recovery of the Q internal standard.  Standard 
curves for Q4 and Q10 were used for Q6 and Q8 
quantification, respectively. 
4-HP8 purification and characterization 
12L of LB culture of ∆ubiI cells in stationary 
phase were centrifuged (4000 rpm, 15 minutes) 
and cell pellet mass was determined (30g). Lipid 
extraction was performed for at least ten cycles at 
50°C with 150 mL of acetone using a Soxhlet 
extractor. The extract was concentrated with a 
rotary evaporator, resuspended in chloroform and 
applied on a silica column (M60, Macherey Nagel 
©). Elution of molecules was realized with 100% 
of chloroform.  Compounds of interest were 
collected in glass tubes and 4-HP8 was further 
purified by HPLC with 40% acetonitrile, 40% 
ethanol and 20% of a mix of 90% isopropanol and 
10% of water. Oxidized and reduced forms of 4-
HP8 were purified based on their characteristic UV 
spectra (see Fig. S3D). NMR spectra were 
recorded on a Bruker EMX 300 MHz spectrometer 
with D6-ethanol as solvent. Mass spectrometry 
measurements were carried out as described in 
supplementary text. 
Expression and Purification 
Overexpression of UbiI was achieved by using 
BL21 (DE3) E.coli strain (Novagen) transformed 
with pET-ubiI-his6. The cultures were grown at 
37°C until they reached OD600 = 0.4, and then 
shifted to 20°C for induction. IPTG was added to 
0.1 mM, and growth continued overnight. All 
subsequent operations were carried out at 4°C. 
Cells were harvested by centrifugation. The cell 
pellet was resuspended in 50 mM Tris-HCl, pH 
7.5, 150 mM NaCl, 5 mM DTT, 30% glycerol 
(v/v) and 1 mM Pefabloc (VWR). After 
sonication, the lysate was centrifuged at 180,000 x 
g for 90 min. The resulting supernatant was loaded 
onto Ni-NTA Superflow resin (Qiagen) 
equilibrated with buffer 50 mM Tris-HCl, pH 7.5, 
25 mM imidazole, 150 mM NaCl, 5 mM DTT and 
30% glycerol (v/v). UbiI was eluted with 250 mM 
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imidazole, and after imidazole removal by 
ultrafiltration with Amicon Ultra 30K columns 
(Millipore), the purified protein was found to be 
>95% pure as judged by SDS-PAGE. The purified 
protein was aliquoted and stored at -80°C in 50 
mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM DTT 
and 30% glycerol (v/v). Selenomethionylated UbiI 
was overexpressed according to the indicated 
protocol (18) and purified with the same protocol 
as the native UbiI. 
Limited trypsin proteolysis  
To optimize the conditions of limited proteolysis, 
experiments were first conducted on an analytical 
scale (500 µg of UbiI) where ratios of enzyme 
(trypsin) over substrate (UbiI) ranged from 1:15 to 
1:1,000 (w/w) in a final volume of 200 µL. 
Digestion time was then optimized for a fixed 
enzyme over substrate ratio. Tryptic digestion 
analysis was performed by SDS PAGE. Large-
scale preparation of cleaved UbiI was then carried 
out in 50 mM Tris-HCl buffer, pH 7.5, 30% 
glycerol (v/v) at a protein concentration of 3 
mg/mL. After 2 h of incubation of UbiI (21 mg) 
with trypsin (42 µg) at 37°C, the reaction was 
stopped by the addition of Pefabloc (1mM), 
followed by analytical SDS PAGE. The N-
terminal 40kDa domain which lacks the C-
terminal 6xHis tag was purified on a NiNTA 
Superflow resin by collecting the flow-through 
and concentrated to 6-8 mg/mL in 25 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 10% (v/v) glycerol.  
Protein analysis 
Mass spectrometry analysis (MALDI-TOF) was 
performed to delineate the C-terminal boundary of 
the N-terminal 40 kDa domain of UbiI, with the 
MASCOT software and Findpept tool (SiCaPS 
platform of IMAGIF (Gif-s-Yvette, France). SEC-
MALLS experiments were performed to determine 
the oligomeric state of the protein, in 25 mM Tris-
HCl, pH 7.3, 150 mM NaCl, 10% (v/v) glycerol 
(IMAGIF Structural and Proteomic Biology Unit, 
Gif-s-Yvette, France) . 
Crystallization 
Crystals were grown at 19 °C by the hanging drop 
vapor diffusion method. 1 µL protein (6-8 mg/mL) 
was mixed with 1 µL precipitant solution 
consisting of 0.1 M Tris pH 8.5, 12% (w/v) 
polyethylene glycol 4000, 0.1 M NaCl, 0.2 M 
MgCl2, which led to plate crystals within 2-3 days. 
For the selenomethionylated protein, the 
precipitant solution was 0.1 M Bis-tris propane pH 
9.0, 14% (w/v) polyethylene glycol 4000, 0.1 M 
NaCl, 0.15 M MgCl2. 
Data collection and structure determination were 
carried out as described in supplementary text. 
 
Docking methods 
 
A potential binding site of FAD in UbiItr was 
explored using docking calculations. Comparing 
the binding site residues of FAD in PHBH (1PBE) 
with those in the crystal structure of UbiItr, we 
noted that a number of residues are not favorably 
oriented to allow the docking of FAD. Preliminary 
to docking calculations, a UbiItr monomer was 
thus prepared as follows: i) rotamers of Arg49, 
Arg35 and Asp164 were selected in order to allow 
the one-step insertion of a rigid model of FAD in 
its extended conformation as observed in 1PBE; ii) 
the binding site residues were further energy 
minimized using CHARMm in Discovery Studio 
3.1 (http://accelrys.com). The resulting protein 
structure was then used as the receptor and FAD 
was docked as a flexible ligand using Autodock 
software (19). The docking results place FAD in a 
range of plausible positions spanning the length of 
the binding pocket of UbiItr. Among the best 
docked structures, we detail here a potential 
location of the FAD co-factor in UbiI selected for 
its highest similarity with the conformation 
observed in 1PBE. There is a rather good 
correspondence for ligand-receptor interactions 
between PHBH-FAD (1PBE) and the modeled 
UbiItr-FAD complex (Table S4).   
 
RESULTS  
 
E. coli ∆ubiI synthesizes low Q8 level in aerobic 
conditions 
We constructed a ∆ubiI strain in which the 
ORF of ubiI has been replaced with a kanamycin 
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resistance cassette. ∆ubiI cells display a growth 
comparable to WT cells both on glucose and on 
succinate media (Fig. S2A) unlike ∆ubiH cells, as 
previously observed (9). Evaluation of the cellular 
content in electroactive isoprenoid quinones by 
using electrochemical detection (ECD) of lipid 
extracts after separation by HPLC (17,20) revealed 
that Q8 content in ∆ubiI cells accounted for only 
7% of that in WT cells (Fig. 2A). Furthermore, an 
unknown electroactive compound X could be 
detected (Fig. 2B). The levels of the isoprenoid 
naphtoquinones, demethylmenaquinone (DMK8) 
and menaquinone (MK8) were not significantly 
different in WT and ∆ubiI cells (Fig. 2B and S2B). 
Transformation of ∆ubiI cells with a plasmid 
containing the ubiI ORF restored Q8 content and 
abolished the accumulation of compound X (Fig. 
2A and 2B). ∆ubiI cells grown anaerobically had a 
content of Q8 comparable to that in WT cells (Fig. 
2C, 2D) and accumulation of compound X was 
abolished. As expected, a strong increase in MK8 
content was observed in cells grown anaerobically 
(21). Reversion of the Q8 biosynthetic defect by 
anaerobic growth of ∆ubiI cells is reminiscent of 
the phenotype of a ∆ubiH strain (22) (Fig. 2C, 
2D). Collectively, these data establish that UbiI is 
involved in aerobic Q8 biosynthesis but not in 
MK8 biosynthesis.  
 
E. coli ∆ubiI accumulates 3-octaprenyl-4-
hydroxphenol (4-HP8) 
 Compound X was purified from ∆ubiI 
cells and found to be present in two redox states. 
Analysis by high-resolution mass spectrometry in 
positive mode gave a m/z ratio (M+H+) of 
655.5445 for reduced compound X and 653.5297 
for the oxidized form corresponding respectively 
to chemical formulas of C46H70O2 +H+ (M = 
C46H70O2 : 654.53755; ppm, 1.3) and C46H68O2 
+H+ (M = C46H68O2: 652.5219; ppm, 0). 
Fragmentation of the 653.5 molecular ion yielded 
a characteristic tropylium-like ion (C7H7O2+), 
often found for aromatic compounds containing a 
benzyl unit, in addition to fragments 
corresponding to loss of methine, methylene or 
methyl groups of an octaprenyl tail in the molecule 
(Fig. S3A). These data are consistent with 
compound X being a phenyl ring functionalized 
with an octaprenyl tail and either two OH groups 
in the reduced (quinol) C46H70O2 molecule or two 
keto groups in the oxidized (quinone) C46H68O2 
molecule (Fig. S3B). The 1H NMR spectrum of 
the purified C46H70O2 compound shows well-
defined peaks both in the aromatic and aliphatic 
regions (Fig. S3C). Most of the signals in the 3.2-
5.3 ppm region could be attributed to the vinylic 
and allylic protons of the octaprenyl substituent. 
The aromatic region of the spectrum shows more 
relevant information. Three distinguishable 
massifs, each corresponding to a unique proton, 
can be observed at 6.44 ppm (doublet of doublet 
with 4J and 3J coupling constants), 6.57 ppm 
(doublet with a 4J coupling constant) and 6.61 ppm 
(doublet with a 3J coupling constant) (Fig. 2E). 
These results confirm a 1, 2, 4-trisubstitution of 
the phenyl ring. The NMR spectrum of the 
commercially available 2-methyl-4-hydroxyphenol 
shows a highly similar pattern with close chemical 
shifts and coupling constants (Fig. 2E). The NMR 
data thus establish the two hydroxyl groups of the 
C46H70O2 compound are in para relative position. 
Accordingly, the UV spectra of oxidized and 
reduced forms of compound X and of 2-methyl-4-
hydroxyphenol are comparable (Fig. S3D, S3E). 
Collectively, all these data identify 3-octaprenyl-4-
hydroxyphenol (4-HP8, Fig. 2F) as the compound 
that accumulates in ∆ubiI cells. 
 
UbiI complements a C5-hydroxylation defect in S. 
cerevisiae 
Drastic decrease of Q8 and accumulation 
of 4-HP8, lacking a OH or a OCH3 group at C5, is 
a strong indication that the C5-hydroxylation 
reaction is deficient in E. coli ∆ubiI cells and that 
UbiI functions as a C5-hydroxylase in Q8 
biosynthesis. To verify this hypothesis, we tested 
whether heterologous expression of UbiI was able 
to complement a S. cerevisiae ∆coq6 strain which 
lacks the C5-hydroxylase Coq6 (17). In 
combination with Coq8 over-expression, required 
for maintaining the integrity of the Q biosynthetic 
complex in S. cerevisiae (23), the mitochondria-
targeted E. coli UbiI protein was found to partially 
restore respiratory growth of ∆coq6 cells on 
lactate-glycerol medium, a process that requires 
coenzyme Q (Fig. 3A). HPLC-ECD analysis of 
cellular lipid extracts of ∆coq6 /Coq8+UbiI cells 
demonstrated the presence of Q6 together with 4-
HP6 (Fig. 3B) whereas ∆coq6 /Coq8 cells 
accumulated exclusively 4-HP6 (17). 
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Complementation by UbiI is not optimal but is 
nevertheless significant since ∆coq6 /Coq8+UbiI 
cells contain about 12% of the amount of Q6 
present in ∆coq6 /Coq6 cells (Fig. 3C). These 
results establish that UbiI can function as a C5-
hydroxylase in S. cerevisiae.  
 
The residual C5-hydroxylase activity in ∆ubiI cells 
is provided by UbiF 
∆ubiI cells synthesize a small amount of 
Q8 (Fig. 2A), reflecting that the C5-hydroxylation 
activity, although limited, is still taking place. In 
order to test the involvement of genes of the Q 
pathway in this biosynthetic activity, we 
constructed ∆ubiF ∆ubiI and ∆ubiE ∆ubiI mutants. 
∆ubiE cells accumulate the biosynthetic 
intermediate C2-demethyl-C6-demethoxy-Q8 
(DDMQ8, peak at 6.87 min. in Fig. 4A), as 
published before (7). Deletion of ubiI in a ∆ubiE 
strain led to the accumulation of 4-HP8 and of a 
diminished amount of DDMQ8 (Fig. 4A). In 
contrast, deletion of ubiI in the ∆ubiF strain 
caused the expected accumulation of 4-HP8 but 
also the complete disappearance of DMQ8 (Fig. 
4B), showing that the C5-hydroxylation reaction is 
totally abolished in the ∆ubiF ∆ubiI strain. 
Collectively, these results demonstrate that the 
residual C5-hydroxylase activity observed in ∆ubiI 
cells is provided by UbiF, the C6-monooxygenase. 
 
Crystal structure of a C-terminal truncated form 
of UbiI  
 We overexpressed and purified the UbiI-
his6 protein which contains a C-terminal hexa-
histidine tag. However, the protein was cofactor-
free, as shown by UV-vis spectroscopy, and highly 
unstable, with a significant propensity to aggregate 
and precipitate. Limited trypsin proteolysis of 
UbiI-his6 generated a soluble fragment (MW~40 
kDa, Fig. S4A). MALDI-TOF mass spectrometry 
of the truncated UbiI (UbiItr) (Fig. S4B) together 
with the result that UbiItr does not bind to Ni-
NTA, suggested that ~ 35 residues at the C-
terminus had been removed (two cleavage sites 
after residue 364 and 365 respectively), as 
confirmed below by the crystal structure of UbiItr. 
The truncated UbiItr protein expressed from a 
plasmid was not able to complement the ∆ubiI 
strain since the quinone profile was similar to that 
of ∆ubiI cells containing an empty vector (Fig. 
S4C). UbiItr behaved as a tetramer in solution, as 
shown by SEC-MALLS experiments (Fig. S4D), 
and crystallized in space group P21212.  
The structure of the native UbiItr protein was 
solved at 2.8 Å resolution by the single anomalous 
dispersion method using the selenomethionylated 
protein and refined to 2.0 Å resolution (Table S2 
and Fig. S5). The overall tertiary structure of the 
tetramer reveals that each monomer contains a 
typical FAD-binding domain with a Rossman-like 
β/α/β-fold (Fig. 5A). A search for proteins with 
similar fold with DALI (24) indicates that the 
structure of UbiItr is similar to that of several 
flavin-dependent monooxygenases including p-
hydroxybenzoate hydroxylase (PHBH) from 
Pseudomonas fluorescens (Table S3). 
Superimposition of the structure of UbiItr with that 
of PHBH in complex with FAD (Fig. 5B) supports 
the presence of a FAD binding pocket in UbiItr.  
 
The FAD binding site in UbiItr  
The existence of a binding site for a FAD 
cofactor in UbiI was confirmed with docking 
experiments and minimization simulations using a 
UbiItr monomer and the extended conformation of 
FAD from PHBH (1PBE) as the starting position 
(25). The results of these calculations are shown in 
Figure 5C. The docked FAD in UbiItr exhibits a 
number of canonical interactions reminiscent of 
those involving FAD in PHBH, especially at the 
isoalloxazine ring and the ribityl chain (Fig. 5C, 
Table S4).  
Figure 5C shows that the isoalloxazine 
ring is located within hydrogen bonding distances 
of the main-chain nitrogens of L297, V302, N303, 
and A52, and the side-chain amide nitrogen atom 
of N303. Also, it may be stabilized by pi-stacking 
with F269, an interaction shared in a number of 
other flavoproteins  (26-28). The ribityl chain is 
hydrogen bonded to side chains of R49 and N110, 
as it is in PHBH using R44 and Q102. Finally, the 
negatively charged pyrophosphate group is 
electrostatically complemented by: (i) the α1 helix 
dipole of the β/α/β-fold at the N-terminus as in 
PHBH, (ii) hydrogen bonding with the side chain 
of R49 residue (R44 in PHBH) and the main chain 
of M13, a residue within the conserved GxGxxG 
motif of flavoproteins (S13 in PHBH).  
Our model of the docked FAD in UbiItr 
was validated by site-directed mutagenesis. We 
UbiI fonctions in Escherichia coli coenzyme Q biosynthesis 
 7 
indeed mutated both residues G301 and N303, 
which are conserved in flavoprotein  
monooxygenases (29)(Fig. S1). These residues 
form the bottom of the isoalloxazine binding 
pocket in UbiItr. Expression of UbiI-G301A-
N303D in the ∆ubiI strain led to a Q8/4-HP8 ratio 
comparable to that found in ∆ubiI cells containing 
an empty vector (Fig. 5D). In contrast, expression 
of UbiI led to the complete disappearance of 4-
HP8 (Fig. 2B). These results show that the G301A-
N303D double mutation strongly impairs UbiI 
activity probably as the consequence of a steric 
effect from the G301A mutation and the 
substitution of a hydrogen-bond stabilization by a 
repulsive electrostatic interaction resulting from 
the N303D mutation, both predicted to 
substantially affect the binding of FAD.  
  
 
DISCUSSION 
By using a combination of genetic, 
biochemical and structural approaches, we have 
established that visC, a gene of unknown function 
in E. coli, encodes a protein that plays an 
important role in coenzyme Q biosynthesis under 
aerobic conditions. Consequently we have 
renamed this gene ubiI. We show here that the 
UbiI protein functions in the C5-hydroxylation 
reaction of aerobic Q biosynthesis in E. coli.  
More precisely, the function of the UbiI 
protein is to introduce the OH group on the C5 
carbon of the phenyl ring of ubiquinone as 
supported by several lines of evidence. First, 4-
HP8 which accumulates in ∆ubiI cells is diagnostic 
of a deficiency in the C5-hydroxylation reaction. 
Indeed, 4-HP8 results from decarboxylation of 
OHB (reaction b, Fig. 1) to form OPP, which is 
then hydroxylated at position C1 (reaction e) 
without C5-hydroxylation (reaction c) and O5-
methylation (reaction d) taking place. Likewise, 
we have shown that S. cerevisiae strains deficient 
for the C5-hydroxylation accumulate 4-HP6 
(17,20). Second, UbiI complements the C5-
hydroxylation defect of ∆coq6 S. cerevisiae cells 
(Fig. 3), which shows that UbiI is a functional 
ortholog of the C5-hydroxylase Coq6. Given the 
modest sequence identity between UbiI and Coq6 
(25%) and the fact that Coq proteins are organized 
in a multiprotein complex (3), it is not surprising 
that UbiI does not fully complement the deletion 
of coq6 (Fig. 3C). Third, we have established that 
UbiI displays a number of characteristics of FAD-
dependent monooxygenases: (i) it shows high 
sequence homology with members of this class of 
enzymes, including the well studied PHBH and 
also UbiH, UbiF and Coq6 (Fig. S1); (ii) the 
crystal structure of UbiItr shows great structural 
homology with PHBH, including at the level of a 
binding pocket for a FAD cofactor, as confirmed 
by docking experiments; (iii) G301 and N303 
which contribute to the FAD binding pocket are 
important for the C5-hydroxylase activity of UbiI. 
On the basis of these results, we propose that UbiI 
is a FAD-dependent monooxygenase which 
catalyzes the O2-dependent C5-hydroxylation 
reaction of coenzyme Q8 biosynthesis in aerobic 
conditions.  
It should be noted that very few Ubi 
proteins involved in Q8 ring modification have 
been characterized biochemically, maybe as a 
result of limited stability and solubility when these 
proteins are expressed individually, as encountered 
with UbiI. In fact only the purified O-
methyltransferase UbiG has been shown to display 
in vitro activity so far (6). In the case of UbiI, we 
had to work with a truncated form lacking 34 
amino acids in the C-terminus to obtain a 
homogeneous protein in solution that we could 
crystallize. Unfortunately, this protein was 
inactive when assayed in vivo and could not bind 
FAD in vitro. Further studies are required to 
obtain a pure active UbiI enzyme. Nevertheless, 
our structure of UbiI is the first X-ray crystal 
structure of a monooxygenase implicated in Q 
biosynthesis.  
A fascinating question raised by our work 
concerns the role of UbiB in Q biosynthesis. We 
clearly show that UbiI is responsible for the C5-
hydroxylation reaction and therefore UbiB is not 
catalyzing this step as this has been thought for 
years (4). An attractive possibility is that UbiB 
functions in regulating Q8 biosynthesis via its 
putative kinase activity as originally proposed by 
Clarke and coworkers (12). If so, the function of 
UbiB would be consistent with the emerging 
function of its eukaryotic homologs from S. 
cerevisiae (Coq8) (23) and humans 
(ACDK3/CABC1)(30).  
Our characterization of ubiI yielded 
intriguing observations regarding the 
hydroxylation reactions. First, inactivation of ubiI 
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does not completely abrogate Q8 biosynthesis. We 
have shown that in the absence of UbiI, the C6 
monooxygenase UbiF is able to hydroxylate the 
neighbouring C5, which points to a relatively poor 
regioselectivity of UbiF. However, there is no 
doubt that the main C5-hydroxylase is UbiI and 
not UbiF since UbiF only promotes the 
biosynthesis of 7% of WT Q8 levels in ∆ubiI cells 
and since the C5-hydroxylation is not deficient in 
∆ubiF cells because only DMQ8 but no 4-HP8 is 
detected in these cells.  Second, we have shown 
that UbiI is dispensable for anaerobic Q8 
biosynthesis similarly to what was reported for 
UbiH and UbiF (22). As dioxygen is the source of 
the three oxygen atoms which are incorporated 
during the aerobic hydroxylation reactions (c, e 
and g, Fig. 1) of Q8 biosynthesis (31), the flavin-
dependent monooxygenases UbiF, UbiH and UbiI 
do not function in anaerobic conditions. Therefore, 
an alternative unidentified enzymatic system must 
substitute for UbiI, UbiF and UbiH in order to 
catalyze the hydroxylation reactions during 
anaerobic Q8 biosynthesis. The next challenge will 
be to identify the anaerobic hydroxylation system. 
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FOOTNOTES 
 
The atomic coordinates for the crystal structure of Ubitr are available in the Protein Data Bank under 
reference 4K22.  
7The abbreviations used are: coenzyme Q (Q), coenzyme Q8 (Q8), C6-demethoxy-Q8 (DMQ8), C1-
demethyl-C6-demethoxy-Q8 (DDMQ8), 3-octaprenyl-4-hydroxybenzoic acid (OHB), 3-octaprenylphenol 
(OPP), 3-octaprenyl-4-hydroxyphenol (4-HP8), 3-hexaprenyl-4-hydroxyphenol (4-HP6), 
demethylmenaquinone  (DMK8), menaquinone (MK8) para-hydroxybenzoate hydroxylase (PHBH), 4-
hydroxybenzoic acid (4-HB), high performance liquid chromatography-electrochemical detection (HPLC-
ECD), flavin adenine dinucleotide (FAD), Size Exclusion Chomatography - Multi-Angle Laser Light 
Scattering (SEC-MALLS) 
 
FIGURE LEGENDS 
Figure 1. Biosynthetic pathway of coenzyme Q8 in E.coli.  
The numbering of the aromatic carbon atoms used throughout this study is shown on Q8 and the 
octaprenyl tail is represented by R on carbon 3 of the different biosynthetic intermediates. The name of 
the enzymes catalyzing the reactions (each labelled with a lower case letter) is indicated. The enzyme 
catalyzing the C5-hydroxylation (reaction c) is unknown (see full text for further details). Abbreviations 
for coenzyme Q8 (Q8), C6-demethoxy-Q8 (DMQ8), C1-demethyl-C6-demethoxy-Q8 (DDMQ8), 3-
octaprenyl-4-hydroxybenzoic acid (OHB) and 3-octaprenylphenol (OPP) are underlined.  
 
Figure 2. ∆ubiI cells have a decreased Q8 content in aerobic conditions and accumulate 3-octaprenyl-4-
hydroxyphenol (4-HP8).  
A) Quantification of cellular Q8 content (n=6-8) in lipid extracts from WT and ∆ubiI cells containing an 
empty vector pBAD (vec) or pBAD-ubiI. Error bars are standard deviation. B) HPLC separation and 
electrochemical detection (HPLC-ECD) of lipid extracts from 2 mg of the same cells as in A. The peaks 
corresponding to Q8, compound X, demethylmenaquinone (DMK8), menaquinone (MK8) and to the Q10 
standard are marked. C) HPLC-ECD of lipid extracts from 2mg of ∆ubiI cells (in black) or ∆ubiH cells 
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(in grey) grown in aerobic (dashed lines) or anaerobic conditions (solid lines). D) Quantification of 
cellular Q8 content of cells described in A (n=3). Error bars are standard deviation. E) Superimposition of 
the aromatic region of the 1H NMR spectra of compound X and of commercial 2-methyl-4-
hydroxyphenol (2M4HP) in D6-ethanol. F) Chemical structure of 4-HP8.  
 
Figure 3. UbiI displays C5-hydroxylase activity in S. cerevisiae.  
A) S. cerevisiae ∆coq6 cells transformed with pRS416-COQ6 plasmid encoding Coq6, an empty vector 
(vec) or with pRS426 TDH3-ubiI, an episomal vector encoding UbiI in combination or not with pRS423-
COQ8 were grown in YNB-pABA-folate 2% galactose 0.4% glucose for 24 h and serial dilutions were 
spotted onto agar plates. The plates contained synthetic medium-pABA-folate + 10uM 4-HB with either 
2% glucose or 2% lactate-2% glycerol. The plates were incubated for 2 days (glucose) or 4 days (lactate-
glycerol) at 30 °C. B) HPLC-ECD of lipid extracts from 2mg of ∆coq6 cells expressing Coq6 or from 6 
mg of ∆coq6 cells expressing UbiI in combination with Coq8. Cells were grown in YNB-pABA- folate 
2% lactate-2% glycerol supplemented with 10 uM 4-HB. Peaks corresponding to demethoxy-Q6 (DMQ6), 
Q6, 3-hexaprenyl-4-hydroxyphenol (4-HP6) and to the Q4 standard are marked. C) Q6 content of ∆coq6 
cells containing either pRS416-COQ6 or pRS426 TDH3-ubiI in combination with pRS423-COQ8, were 
grown in the same medium as in B. Error bars are standard deviation (n = 4).  
 
Figure 4. UbiF is responsible for the residual C5-hydroxylation in the absence of UbiI.  
A) HPLC-ECD of lipid extracts from 2mg of WT cells (dashed black line), ∆ubiE cells (in grey) or 
∆ubiE∆ubiI cells (in black). B) HPLC-ECD of lipid extracts from 2mg of ∆ubiF cells (in grey) or 
∆ubiF∆ubiI cells (in black). 
 
Figure 5. Crystal structure of a truncated form of UbiI and its FAD binding site.  
A) Ribbon diagram of the crystal structure of tetrameric UbiItr. Each subunit is represented with a 
different colour with the β/α/β Rossman-like fold of one subunit highlighted in orange. B) DALI 
superimposition of UbiItr (blue) with PHBH (yellow, pdb: 1PBE) and the FAD of PHBH shown as ball 
and sticks. The r.m.s.d. is 3.0 Å for 327 Cα. C) Docking of FAD in UbiItr. Residues involved in hydrogen 
bonding and pi−type interactions are represented. See details in Table S4. D) Corrected integration of the 
electrochemical signal for the peaks corresponding to Q8 (in black) and 4-HP8 (in grey) after HPLC 
analysis of lipid extracts from ∆ubiI cells containing an empty vector, pBAD-ubiI or pBAD-ubiI[G301A-
N303D] (n=4). The ratio of the area of the Q8 and 4-HP8 peaks is indicated. 
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